当前位置： SCI文献检索 > BMC CANCER期刊下所有文献 > A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation.

Abstract：

BACKGROUND:Patients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and ablation, to prevent tumor progression and dropout and to improve long-term outcome after transplantation. We wanted to prospectively assess feasibility of systemic antitumor treatment with sorafenib as neoadjuvant treatment for hepatocellular carcinoma while waiting for liver transplantation, evaluating tolerability, toxicity and posttransplant morbidity. We also wanted to evaluate perfusion CT parameters to assess tumor properties and response early after start of sorafenib treatment in patients with early hepatocellular carcinoma. METHODS:Twelve patients assigned for liver transplantation due to hepatocellular carcinoma, within the UCSF and who fulfilled other criteria, were included January 2012-August 2014. After baseline evaluation, sorafenib treatment was started. Treatment was evaluated by perfusion CT at 1, 4 and 12 weeks and thereafter every 8 weeks. Toxicity and quality of life was assessed at 1 and 4 weeks and every 4 weeks thereafter during treatment. Treatment was stopped when patients were prioritized on the transplantation waiting list or when intolerable side effects or tumor progress warranted other treatments. Posttransplant morbidity after 90 days was registered according to Clavien-Dindo. RESULTS:Baseline perfusion CT parameters in the tumors predicted the outcome according to RECIST/mRECIST at three months, but no change in CTp parameters was detected as a result of sorafenib. Sorafenib as neoadjuvant treatment was associated with intolerability and dose reductions. Therefore the prerequisites for evaluation of the sorafenib effect on both CT parameters and tumor response were impaired. CONCLUSIONS:This study failed to show changes in CTp parameters during sorafenib treatment. Despite the curative treatment intention, tolerability of neoadjuvant sorafenib treatment before liver transplantation was inadequate in this study. TRIAL REGISTRATION:EudraCT number: 2010-024306-36 (date 2011-04-07).

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Eilard MS,Andersson M,Naredi P,Geronymakis C,Lindnér P,Cahlin C,Bennet W,Rizell M

doi

10.1186/s12885-019-5760-8

subject

Has Abstract

pub_date

2019-06-11 00:00:00

pages

568

issue

1

issn

1471-2407

pii

10.1186/s12885-019-5760-8

journal_volume

19

pub_type

临床试验,杂志文章

相关文献

BMC CANCER文献大全
  • Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.

    abstract：BACKGROUND:Patients with metastatic renal carcinoma frequently have pre-existing renal impairment and not infrequently develop worsening renal function as a complication of their treatment. The presence of pancreatic metastases in patients with metastatic renal carcinoma, often confers a more favourable prognosis and a...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6215-y

    authors： Purshouse K,Chamberlain S,Soares M,Tuthill M,Protheroe A,Mole DR

    更新日期：2019-10-17 00:00:00

  • Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.

    abstract：BACKGROUND:There is now a renewed interest in cancer vaccines. Patients responding to immune checkpoint blockade usually bear tumors that are heavily infiltrated by T cells and express a high load of neoantigens, indicating that the immune system is involved in the therapeutic effect of these agents; this finding stron...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4094-2

    authors： Thomas SK,Cha SC,Smith DL,Kim KH,Parshottam SR,Rao S,Popescu M,Lee VY,Neelapu SS,Kwak LW

    更新日期：2018-02-13 00:00:00

  • miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.

    abstract：BACKGROUND:MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene expression regulation and have been described as key regulators of carcinogenesis. Aberrant miRNA expression has been frequently reported in sporadic breast cancers, but few studies have focused on profiling hereditary breast ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-6640-y

    authors： Pessôa-Pereira D,Evangelista AF,Causin RL,da Costa Vieira RA,Abrahão-Machado LF,Santana IVV,da Silva VD,de Souza KCB,de Oliveira-Silva RJ,Fernandes GC,Reis RM,Palmero EI,Marques MMC

    更新日期：2020-02-22 00:00:00

  • Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.

    abstract：BACKGROUND:Pelvic inflammatory disease (PID) is characterized by infection and inflammation of the upper genital tract in women and is associated with health sequelae. We used a nationwide population-based retrospective cohort study to explore the relationship between PID and the subsequent development of gynecological...

    journal_title：BMC cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1186/s12885-016-2857-1

    authors： Shen CC,Hu LY,Yang AC,Chiang YY,Hung JH,Tsai SJ

    更新日期：2016-11-03 00:00:00

  • Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.

    abstract：BACKGROUND:Preclinical research indicate that vascular disrupting agent (VDA) treatment induces extensive tumor death but also a systemic mobilization of bone marrow derived cells including endothelial progenitor cells (EPC) leading to revascularization and renewed growth within the residual tumor. This study investiga...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2568-7

    authors： Nguyen L,Fifis T,Christophi C

    更新日期：2016-07-26 00:00:00

  • COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.

    abstract：BACKGROUND:Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature cells that accumulates in tumour-bearing hosts. These cells are induced by tumour-derived factors (e.g. prostaglandins) and have a critical role in immune suppression. MDSC suppress T and NK cell function via increased express...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-10-464

    authors： Veltman JD,Lambers ME,van Nimwegen M,Hendriks RW,Hoogsteden HC,Aerts JG,Hegmans JP

    更新日期：2010-08-30 00:00:00

  • RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.

    abstract：BACKGROUND:Liver resection had been regarded as a standard treatment for primary hepatocellular carcinoma (HCC). However, early mortality and recurrence after surgery were still of major concern. RAM (Risk Assessment for early Mortality) scoring system is a newly developed tool for assessing early mortality after hepat...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3748-9

    authors： Hsu HY,Yu MC,Lee CW,Tsai HI,Sung CM,Chen CW,Huang SW,Lin CY,Jeng WJ,Lee WC,Chen MF

    更新日期：2017-11-09 00:00:00

  • Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.

    abstract：BACKGROUND:Despite considerable efforts by scientific research, pancreatic cancer is the fourth leading cause of cancer related mortalities. Sigma-2 receptors, which are overexpressed in several tumors, represent promising targets for triggering selective pancreatic cancer cells death. METHODS:We selected five differe...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-3040-4

    authors： Pati ML,Hornick JR,Niso M,Berardi F,Spitzer D,Abate C,Hawkins W

    更新日期：2017-01-13 00:00:00

  • Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.

    abstract：BACKGROUND:Recent data in esophageal cancer suggests the variant allele of a single-nucleotide polymorphism (SNP) in XRCC1 may be associated with resistance to radiochemotherapy. However, this SNP has not been assessed in a histologically homogeneous clinical trial cohort that has been treated with a uniform approach. ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-11-176

    authors： Yoon HH,Catalano PJ,Murphy KM,Skaar TC,Philips S,Powell M,Montgomery EA,Hafez MJ,Offer SM,Liu G,Meltzer SJ,Wu X,Forastiere AA,Benson AB,Kleinberg LR,Gibson MK

    更新日期：2011-05-17 00:00:00

  • Angiopoietin-1 deficiency increases tumor metastasis in mice.

    abstract：BACKGROUND:Angipoietin-1 activation of the tyrosine kinase receptor Tek expressed mainly on endothelial cells leads to survival and stabilization of endothelial cells. Studies have shown that Angiopoietin-1 counteracts permeability induced by a number of stimuli. Here, we test the hypothesis that loss of Angiopoietin-1...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3531-y

    authors： Michael IP,Orebrand M,Lima M,Pereira B,Volpert O,Quaggin SE,Jeansson M

    更新日期：2017-08-11 00:00:00

  • Barriers and facilitators to smoking cessation in a cancer context: A qualitative study of patient, family and professional views.

    abstract：BACKGROUND:Continued smoking after cancer adversely affects quality of life and survival, but one fifth of cancer survivors still smoke. Despite its demands, cancer presents an opportunity for positive behaviour change. Smoking often occurs in social groups, therefore interventions which target families and individuals...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3344-z

    authors： Wells M,Aitchison P,Harris F,Ozakinci G,Radley A,Bauld L,Entwistle V,Munro A,Haw S,Culbard B,Williams B

    更新日期：2017-05-19 00:00:00

  • Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.

    abstract：BACKGROUND:Phosphatase of regenerating liver-3 (PRL-3) has deserved attention as a crucial molecule in the multiple steps of metastasis. In the present study, we examined the mechanisms regulating PRL-3 expression, and assessed the clinical potential of PRL-3-targeted therapy in gastric cancer. METHODS:PRL-3 genomic a...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-11-122

    authors： Ooki A,Yamashita K,Kikuchi S,Sakuramoto S,Katada N,Waraya M,Kawamata H,Nishimiya H,Nakamura K,Watanabe M

    更新日期：2011-04-06 00:00:00

  • Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.

    abstract：BACKGROUND:Extravasation of circulating cancer cells is a key event of metastatic dissemination that is initiated by the adhesion of cancer cells to endothelial cells. It requires interactions between adhesion receptors on endothelial cells and their counter-receptors on cancer cells. Notably, E-selectin, a major endot...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-11-285

    authors： Porquet N,Poirier A,Houle F,Pin AL,Gout S,Tremblay PL,Paquet ER,Klinck R,Auger FA,Huot J

    更新日期：2011-07-01 00:00:00

  • FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes.

    abstract：BACKGROUND:FAM3B/PANDER is a novel cytokine-like protein that induces apoptosis in insulin-secreting beta-cells. Since in silico data revealed that FAM3B can be expressed in prostate tumors, we evaluated the putative role of this cytokine in prostate tumor progression. METHODS:FAM3B expression was analyzed by quantita...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3950-9

    authors： Maciel-Silva P,Caldeira I,de Assis Santos I,Carreira ACO,Siqueira FR,Antonioli E,Goldberg AC,Belizário JE,Garay-Malpartida HM

    更新日期：2018-01-22 00:00:00

  • INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.

    abstract：BACKGROUND:Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells. Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor β (TGFβ) in situ, w...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2473-0

    authors： Yu Y,Huang R,Zong X,He X,Mo W

    更新日期：2016-07-07 00:00:00

  • Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.

    abstract：BACKGROUND:Breast cancer is the most common invasive cancer among women. Currently, there are only a few models used for therapy selection, and they are often poor predictors of therapeutic response or take months to set up and assay. In this report, we introduce a microfluidic OrganoPlate® platform for extracellular m...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-017-3709-3

    authors： Lanz HL,Saleh A,Kramer B,Cairns J,Ng CP,Yu J,Trietsch SJ,Hankemeier T,Joore J,Vulto P,Weinshilboum R,Wang L

    更新日期：2017-11-02 00:00:00

  • Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

    abstract：BACKGROUND:Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce type I interferons and other cytokines, which drive an inflammatory response and activate the adaptiv...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-10-665

    authors： González-Reyes S,Marín L,González L,González LO,del Casar JM,Lamelas ML,González-Quintana JM,Vizoso FJ

    更新日期：2010-12-03 00:00:00

  • Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA.

    abstract：BACKGROUND:Solitary plasmacytoma (SP) is a localized neoplastic plasma cell disorder with an annual incidence of less than 450 cases. Given the rarity of this disorder, it is difficult to conduct large-scale population studies. Consequently, very limited information on the disorder is available, making it difficult to ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-3015-5

    authors： Thumallapally N,Meshref A,Mousa M,Terjanian T

    更新日期：2017-01-05 00:00:00

  • MiR-200c/FUT4 axis prevents the proliferation of colon cancer cells by downregulating the Wnt/β-catenin pathway.

    abstract：BACKGROUND:MicroRNA (miR)-200c has been widely reported to be involved in colon cancer progress. However, the mechanisms of miR-200c in regulating tumor metastasis and growth remain to be fully elucidated. This study aimed to investigate the mechanism of miR-200c targets fucosyltransferase 4 (FUT4) on the proliferation...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-07670-y

    authors： Cong J,Gong J,Yang C,Xia Z,Zhang H

    更新日期：2021-01-04 00:00:00

  • CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.

    abstract：BACKGROUND:In past decades, circular RNAs (circRNAs) have achieved increasing attention because of its regulatory role in different kinds of cancers. However, how circAGFG1 regulates cervical cancer (CC) is still largely undiscovered. This study aims to evaluate the role of a novel circRNAs and related molecular mechan...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-019-6269-x

    authors： Wu F,Zhou J

    更新日期：2019-11-08 00:00:00

  • More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells.

    abstract：BACKGROUND:Brain-derived neurotrophic factor (BDNF) has been reported to promote tumorigenesis and progression in several human malignancies. The purpose of this study was to explore the function of BDNF in lung squamous cell carcinoma (SCC) and adenocarcinoma (ADC). METHODS:The expression of BDNF was examined in 110 ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2218-0

    authors： Zhang SY,Hui LP,Li CY,Gao J,Cui ZS,Qiu XS

    更新日期：2016-02-29 00:00:00

  • The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.

    abstract：BACKGROUND:C3H mice have been frequently used in cancer studies as animal models of spontaneous liver tumors and chemically induced hepatocellular carcinoma (HCC). Epigenetic modifications, including DNA methylation, are among pivotal control mechanisms of gene expression leading to carcinogenesis. Although information...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-018-4221-0

    authors： Matsushita J,Okamura K,Nakabayashi K,Suzuki T,Horibe Y,Kawai T,Sakurai T,Yamashita S,Higami Y,Ichihara G,Hata K,Nohara K

    更新日期：2018-03-22 00:00:00

  • Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.

    abstract：BACKGROUND:Transforming growth factor (TGF)-β plays a pivotal role in cancer progression through regulating cancer cell proliferation, invasion, and remodeling of the tumor microenvironment. Cancer-associated fibroblasts (CAFs) are the predominant type of stromal cell, in which TGF-β signaling is activated. Among the s...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-580

    authors： Horie M,Saito A,Noguchi S,Yamaguchi Y,Ohshima M,Morishita Y,Suzuki HI,Kohyama T,Nagase T

    更新日期：2014-08-09 00:00:00

  • Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer.

    abstract：BACKGROUND:The clinical implication of Ras/Raf/ERK pathway activity in breast cancer tissue and its association with response to chemotherapy is controversial. We aimed to explore the value of p90RSK phosphorylation, a downstram molecule of the pathway, in predicting chemotherapy response in breast cancer. METHODS:The...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-12-585

    authors： Moon HG,Yi JK,Kim HS,Lee HY,Lee KM,Yi M,Ahn S,Shin HC,Ju JH,Shin I,Han W,Noh DY

    更新日期：2012-12-10 00:00:00

  • Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells.

    abstract：BACKGROUND:Isothiocyanates are natural compounds found in consumable cruciferous vegetables. They have been shown to inhibit chemical carcinogenesis by a wide variety of chemical carcinogens in animal models. Recent studies have also shown that isothiocyanates have antitumor activity, inhibiting the growth of several t...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-10-269

    authors： Wu X,Zhu Y,Yan H,Liu B,Li Y,Zhou Q,Xu K

    更新日期：2010-06-09 00:00:00

  • Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

    abstract：BACKGROUND:Mammalian target of rapamycin (mTOR) inhibitors have anti-tumor effects against renal cell carcinoma, pancreatic neuroendocrine cancer and breast cancer. In this study, we analyzed the antitumor effects of mTOR inhibitors in small cell lung cancer (SCLC) cells and sought to clarify the mechanism of resistanc...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-015-1202-4

    authors： Matsumoto M,Seike M,Noro R,Soeno C,Sugano T,Takeuchi S,Miyanaga A,Kitamura K,Kubota K,Gemma A

    更新日期：2015-04-09 00:00:00

  • Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.

    abstract：BACKGROUND:Median age at diagnosis of patients with chronic lymphocytic leukemia (CLL) is > 70 years. However, the majority of clinical trials do not reflect the demographics of CLL patients treated in the community. We examined treatment patterns, outcomes, and disease-related mortality in patients ≥ 75 years with CLL...

    journal_title：BMC cancer

    pub_type： 临床试验,杂志文章

    doi：10.1186/s12885-017-3176-x

    authors： Nabhan C,Mato A,Flowers CR,Grinblatt DL,Lamanna N,Weiss MA,Davids MS,Swern AS,Bhushan S,Sullivan K,Flick ED,Kiselev P,Sharman JP

    更新日期：2017-03-16 00:00:00

  • Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.

    abstract：BACKGROUND:Renal cell carcinoma (RCC) is a seventh ranked malignancy with poor prognosis. RCC is lethal at metastatic stage as it does not respond to conventional systemic treatments, and there is an urgent need to find out promising novel biomarkers for effective treatment. The goal of this study was to evaluate the b...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-016-2775-2

    authors： Karim S,Al-Maghrabi JA,Farsi HM,Al-Sayyad AJ,Schulten HJ,Buhmeida A,Mirza Z,Al-Boogmi AA,Ashgan FT,Shabaad MM,NourEldin HF,Al-Ghamdi KB,Abuzenadah A,Chaudhary AG,Al-Qahtani MH

    更新日期：2016-09-30 00:00:00

  • The influence of radiotherapy techniques on the plan quality and on the risk of secondary tumors in patients with pituitary adenoma.

    abstract：BACKGROUND:This planning study compares different radiotherapy techniques for patients with pituitary adenoma, including flatness filter free mode (FFF), concerning plan quality and secondary malignancies for potentially young patients. The flatness filter has been described as main source of photon scatter. MATERIAL ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/s12885-020-6535-y

    authors： Treutwein M,Steger F,Loeschel R,Koelbl O,Dobler B

    更新日期：2020-02-03 00:00:00

  • Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.

    abstract：BACKGROUND:The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery. There ...

    journal_title：BMC cancer

    pub_type： 杂志文章

    doi：10.1186/1471-2407-14-492

    authors： Arcolia V,Paci P,Dhont L,Chantrain G,Sirtaine N,Decaestecker C,Remmelink M,Belayew A,Saussez S

    更新日期：2014-07-08 00:00:00